Accessibility Statement Skip Navigation
  • PRNewswire.com
  • Resources
  • +91 22-69790010
  • Client Login
  • Send a Release
PR Newswire: news distribution, targeting and monitoring
  • News
  • Products
  • Contact
When typing in this field, a list of search results will appear and be automatically updated as you type.

Searching for your content...

No results found. Please use Advanced Search to search all press releases.
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Hamburger menu
  • PR Newswire: news distribution, targeting and monitoring
  • Send a Release
    • Telephone

    • +91 22-69790010 from 9 AM - 5:30 PM IST

    • Contact
    • Contact

      +91 22-69790010
      from 9 AM - 5:30 PM IST

  • Request More Information
  • Journalists
  • Request More Information
  • Journalists
  • Explore Our Platform
  • Plan Campaigns
  • Create with AI
  • Distribute Press Releases
  • Amplify Content
  • All Products
  • Request More Information
  • Journalists
  • Request More Information
  • Journalists

Brain Navi achieves U.S. FDA approval for neurosurgical robot NaoTrac
  • USA - English
  • MEXICO - Spanish
  • APAC - English
  • Japan - Japanese

Brain Navi Biotechnology, a leading Taiwanese surgical robotic company, specializes in designing and developing innovative navigation and robotic surgery technologies.

News provided by

Brain Navi Biotechnology Co., Ltd.

17 Jun, 2025, 18:30 IST

Share this article

Share toX

Share this article

Share toX

ZHUBEI CITY, June 17, 2025 /PRNewswire/ -- Brain Navi Biotechnology, a medical robotics company founded in 2015 in Taiwan by surgeon and serial entrepreneur Jerry Chen, has reached another major milestone. Following previous approvals from the Taiwan Food and Drug Administration (TFDA) and the CE Mark for Europe, Brain Navi has now received FDA 510(k) clearance for its stereotaxic guiding surgical device, NaoTrac — reinforcing our commitment to innovation, patient safety, and continuous improvement in the neurosurgical field.

Continue Reading
Dr. Jerry Chen, CEO of Brain Navi, announced the clearance of NaoTrac in U.S FDA
Dr. Jerry Chen, CEO of Brain Navi, announced the clearance of NaoTrac in U.S FDA

For Brain Navi, this is a significant step forward, opening the door to new high-potential markets while affirming the quality and reliability of NaoTrac, our flagship robotic system. This milestone not only expands our global footprint but also validates the years of clinical research and development invested in the technology.

We have received FDA 510(k) clearance, which confirms that NaoTrac is substantially equivalent in safety and effectiveness to legally marketed devices in the U.S. This recognition enables us to bring NaoTrac to U.S. hospitals and surgical teams, helping them achieve even higher levels of precision and efficiency in the operating room and save more lives.

Key Features of NaoTrac

  • Autonomous Navigation: SMART technology enables non-contact, frameless registration by aligning the patient's anatomy with preoperative imaging in seconds.
  • Robotic Precision: The robotic arm assists neurosurgeons in positioning surgical instruments along a planned trajectory, ensuring optimal precision while allowing the surgeon to remain in control.
  • Versatile Clinical Applications: NaoTrac supports a wide range of neurosurgical procedures, including biopsies, tumor ablations, endoscopic interventions, EVD placement, SEEG, and Deep Brain Stimulation (DBS).

NaoTrac combines advanced robotic automation with AI-driven accuracy, aiming to elevate neurosurgical outcomes and improve safety for both surgeons and patients.

This step marks a before-and-after moment for Brain Navi — one that paves the way for broader international adoption. As we move forward, we expect to see more and more NaoTrac systems installed around the world, supporting surgical teams and improving patient care across borders.

Photo - https://mma.prnewswire.com/media/2712635/Jerry_NaoTrac_S_1_1.jpg 
Logo - https://mma.prnewswire.com/media/1873615/5373888/Logo.jpg

Modal title

Also from this source

Brain Navi Biotechnology's NaoTrac performs first surgeries in Spain

Brain Navi Biotechnology's NaoTrac performs first surgeries in Spain

Such an achievement has been made possible through the first of many collaborations with our valued partner, Palex Healthcare. This milestone has...

More Releases From This Source

Explore

Health Care & Hospitals

Health Care & Hospitals

Medical Equipment

Medical Equipment

Medical Pharmaceuticals

Medical Pharmaceuticals

FDA Approval

FDA Approval

News Releases in Similar Topics

Contact PR Newswire

  • +91 22-69790010

Global Sites

  • APAC
  • APAC - Traditional Chinese
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany

 

  • India
  • Indonesia
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Middle East - Arabic
  • Netherlands
  • Norway
  • Poland

 

  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States

Do not sell or share my personal information:

  • Submit via [email protected] 
  • Call Privacy toll-free: 877-297-8921
Global Sites
  • Asia
  • Brazil
  • Canada
  • Czech
  • Denmark
  • Finland
  • France
  • Germany
  • India
  • Israel
  • Italy
  • Mexico
  • Middle East
  • Netherlands
  • Norway
  • Poland
  • Portugal
  • Russia
  • Slovakia
  • Spain
  • Sweden
  • United Kingdom
  • United States
+91 (0) 22 6169 6000
from 9 AM - 5:30 PM IST
  • Terms of Use
  • Privacy Policy
  • GDPR
  • Information Security Policy
  • Site Map
  • Cookie Settings
Copyright © 2025 Cision US Inc.